Kolexia
Heibel Francoise
Néphrologie
Hôpital Civil
Strasbourg, France
51 Activités
34 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} COVID-19 Glomérulonéphrite segmentaire et focale Fractures osseuses Insuffisance rénale Défaillance rénale chronique Fistule artérioveineuse Hydrothorax Virémie Adhérences tissulaires

Industries

AstraZeneca
1 collaboration(s)
Dernière en 2022
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Tixagevimab-cilgavimab as an Early Treatment for COVID-19 in Kidney Transplant Recipients.
Transplantation   20 juillet 2023
A rapid decline in the anti-receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab-cilgavimab administration.
Kidney international   13 août 2022
Prediction of Vaccine Response and Development of a Personalized Anti-SARS-CoV-2 Vaccination Strategy in Kidney Transplant Recipients: Results from a Large Single-Center Study.
Journal of personalized medicine   05 juillet 2022
Breakthrough COVID-19 cases despite prophylaxis with 150 mg of tixagevimab and 150 mg of cilgavimab in kidney transplant recipients.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons   30 juin 2022
Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients.
Science translational medicine   16 mars 2022
SARS-Cov-2 Seroprevalence in a French Kidney Transplant Center Located Within a "High-risk" Zone.
Transplantation   11 octobre 2021
Strong antibody response after a first dose of a SARS-CoV-2 mRNA-based vaccine in kidney transplant recipients with a previous history of COVID-19.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons   23 juillet 2021
Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine.
Kidney international   20 avril 2021
Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients.
Kidney international   26 mars 2021
Biomarkers of Cytokine Release Syndrome Predict Disease Severity and Mortality From COVID-19 in Kidney Transplant Recipients.
Transplantation   06 janvier 2021